specific therapy. This particular field brings along the gene related patent applications. In recent years, ethical sides …, policy considerations on patent applications in gene sequences, and gene related diagnostic and treatment methods led to many … debates among biotech/pharma companies, patent stakeholders, researchers, clinicians, and patients. Although the patent system …

the Australian parliament in 2011. To "raise" the height of the inventiveness requirement for the second-tier patent …

We study the causal impact of invalidating marginally valid patents during post-grant opposition at the European Patent … participation of a patent's original examiner in the opposition division as an instrument. We find a disciplinary effect of … invalidation: Affected inventors file 20% fewer patent applications in the decade after the decision. This effect is entirely …

We study the causal impact of invalidating marginally valid patents during post-grant opposition at the European Patent … participation of a patent's original examiner in the opposition division as an instrument. We find a disciplinary effect of … invalidation: Affected inventors file 20% fewer patent applications in the decade after the decision. This effect is entirely …